Clinical Trials in Pennsylvania

Showing 4561-4580 of 19,675 trials

CCT-102 or Expectant Management in Delayed Pregnancy Loss

NCT06121063

A Phase 3, multi-center clinical trial of a CCT-102 regimen or expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).

Early Pregnancy Loss, Delayed Pregnancy Loss

Conceptra Biosciences, LLC183 participantsStarted Jul 2023

Tucson, Arizona, United States • San Fernando, California, United States • Panama City, Florida, United States +12 more locations

RECRUITING50 miles

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.

Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+13 more

Guardant Health, Inc.2,020 participantsStarted Sep 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Hot Springs, Arkansas, United States +54 more locations

CCT-102 or Expectant Management in Delayed Pregnancy Loss

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Find Trials by Condition in Pennsylvania

Study of JK07 in Patients With Chronic Heart Failure

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

ERG Components in Schizophrenia and Bipolar Disorder Type I

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Oral Contraceptive Pill (OCP) Pharmacogenomics

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)